Pre-pregnancy evaluation of essential hypertensive women with poor obstetric history
Open Access
- 1 January 2026
- journal article
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (4) , e20251913
Abstract
SUMMARY OBJECTIVE: Essential hypertension is linked to increased maternal and perinatal risks. The aim of this study was to assess women with essential hypertension and poor obstetric history before conception to identify co-morbidities and placenta-related risk factors and to examine how preconception evaluation affects future pregnancy outcomes. METHODS: This retrospective cohort study involved women with poor obstetric history, with (n=25) or without (n=243) essential hypertension. Women were evaluated for co-morbidities and metabolic, immunological, inflammatory, and vascular/thrombotic risk factors. Subsequent pregnancies were then assessed for gestational outcomes. RESULTS: Higher levels of co-morbidity were found in the essential hypertension (+) group compared to high-risk controls (68 vs. 39.9%, p=0.013). Essential hypertension (+) women had significantly higher rates of chronic inflammatory diseases (28 vs. 5.8%, p=0.001) and carbohydrate metabolism disorders (44 vs. 10.3%, p<0.001) than in controls. Except for “APGAR<7” (p=0.016), we were unable to show any statistically significant differences between the study and control groups in terms of placenta-related obstetric complications and gestational outcomes in their forthcoming pregnancies due to necessary precautions and timely management of risk factors. CONCLUSION: Chronic inflammatory diseases and carbohydrate metabolism disorders, which are risk factors for both endothelial injury and placenta-related obstetric complications, are more frequently observed in pregnancies with essential hypertension. Preconception counseling is critical in reducing gestational complications.Keywords
This publication has 25 references indexed in Scilit:
- Preeclampsia: Updates in Pathogenesis, Definitions, and GuidelinesClinical Journal of the American Society of Nephrology, 2016
- The benefits/risks of treatment of non‐severe hypertension in pregnancy and choice of drug remain unansweredBJOG: An International Journal of Obstetrics & Gynaecology, 2015
- Control of Hypertension In Pregnancy Study randomised controlled trial—are the results dependent on the choice of labetalol or methyldopa?BJOG: An International Journal of Obstetrics & Gynaecology, 2015
- The Cooperative Roles of Inflammation and Oxidative Stress in the Pathogenesis of HypertensionAntioxidants & Redox Signaling, 2014
- Global and regional estimates of preeclampsia and eclampsia: a systematic reviewEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Hypertension in pregnancy: a review of therapeutic optionsObstetric Medicine, 2012
- Nifedipine in the management of preterm labor: a systematic review and metaanalysisAmerican Journal of Obstetrics and Gynecology, 2011
- Use of nifedipine in the treatment of hypertensionExpert Review of Cardiovascular Therapy, 2005
- Aspirin triggers antiinflammatory 15-epi-lipoxin A 4 and inhibits thromboxane in a randomized human trialProceedings of the National Academy of Sciences, 2004
- ESSENTIAL HYPERTENSION AND PREGNANCY1978